FOI release

Marketing Authorisation application made by Northwest Biotherapeutics

This request was refused in full, so we didn't provide the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2025/00136

Received 10 February 2025

Published 28 March 2025

Request

I am enquiring about the Marketing Authorisation application made by Northwest Biotherapeutics on December 21,2023. If possible, could you please answer the following questions: 1. Was the Marketing application for this company received and if so when? 2. Is this application still being processed on the MHRA's rapid 150 day review pathway? 3. Has a decision be made for this application or is it currently still pending under review?

Response

see attached

Documents

• FOI2025_00136 redacted for publication.pdf (154.5 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.